Home Institutions UCLA Health clinical trials Institution Directory
Clinical trials at UCLA Health Sites in Los Angeles, CA
Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.
ClinicalTrials.gov public records Last synced Oct 25, 2026, 9:49 AM EDT
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official matching trials
1099
Current sort
Recently updated
Campus scope
UCLA Health, Los Angeles, CA
Additional filters apply within this campus.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Showing 433–444 of 1,099 matching trials with a site at UCLA Health, Los Angeles, CA.
Live ClinicalTrials.gov results.
Local aggregate panels are unavailable or hidden for filtered views. The result list above identifies its data source.
Live official records
Conditions Transplant Rejection
Interventions BIVV020 (SAR445088), Intravenous immunoglobulin (IVIg), Rituximab or biosimilar, Antithymocyte globulin (ATG), Tacrolimus, Mycophenolate, Corticosteroids Drug
Lead sponsor Sanofi Industry
Eligibility 18 Years and older
Enrollment 48 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2022 – 2026
U.S. locations 7
States / cities Los Angeles, California • San Francisco, California • Boston, Massachusetts + 2 more
Conditions Recurrent Ovarian Cancer, Folate Receptor-Alpha Positive
Interventions Mirvetuximab Soravtansine, Lubricating Eye Drops, Prednisolone acetate ophthalmic suspension 1% eye drops, Brimonidine tartrate ophthalmic solution eye drops Drug
Lead sponsor AbbVie Industry
Eligibility 18 Years and older · Female only
Enrollment 108 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2024 – 2027
U.S. locations 13
States / cities Los Angeles, California • San Francisco, California • Louisville, Kentucky + 9 more
Conditions Tuberous Sclerosis Complex
Interventions everolimus Drug
Lead sponsor Novartis Pharmaceuticals Industry
Eligibility 2 Years to 65 Years
Enrollment 206 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2017 – 2026
U.S. locations 14
States / cities Phoenix, Arizona • Los Angeles, California • Oakland, California + 11 more
Conditions X-Linked Chronic Granulomatous Disease
Interventions EN-374 Genetic
Lead sponsor Ensoma Industry
Eligibility 3 Months and older · Male only
Enrollment 15 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2027
U.S. locations 8
States / cities Los Angeles, California • San Francisco, California • St. Petersburg, Florida + 5 more
Conditions Stage I Renal Cell Cancer, Stage II Renal Cell Cancer
Interventions Angiogram, Biospecimen Collection, Computed Tomography, Radioembolization, Single Photon Emission Computed Tomography, Survey Administration, Yttrium Y 90 Glass Microspheres Procedure · Radiation · Other
Lead sponsor Jonsson Comprehensive Cancer Center Other
Eligibility 18 Years and older
Enrollment 25 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2024 – 2030
U.S. locations 2
States / cities Los Angeles, California • Aurora, Colorado
Conditions Interstitial Lung Disease, Idiopathic Interstitial Pneumonias, Drug-Induced Pneumonitis, Hypersensitivity Pneumonitis, Radiation Pneumonitis, Pneumoconiosis, Pulmonary Fibrosis
Interventions 68Ga-FAPi-46, Computed Tomography, Positron Emission Tomography, High Resolution Computed Tomography Drug · Procedure
Lead sponsor University of California, Los Angeles Other
Eligibility 18 Years and older
Enrollment 30 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2021 – 2026
U.S. locations 1
States / cities Los Angeles, California
Conditions Intracerebral Hemorrhage
Interventions Recombinant Factor VIIa, Biological/Vaccine: Placebo Biological
Lead sponsor Joseph Broderick, MD Other
Eligibility 18 Years to 80 Years
Enrollment 350 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2029
U.S. locations 49
States / cities Birmingham, Alabama • Baldwin Park, California • Burlingame, California + 39 more
Conditions Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Adult Mixed Glioma, Recurrent Adult Brain Neoplasm
Interventions Laboratory Biomarker Analysis, Pharmacological Study, Temozolomide, Vorinostat Other · Drug
Lead sponsor National Cancer Institute (NCI) NIH
Eligibility 18 Years and older
Enrollment 83 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2005 – 2027
U.S. locations 17
States / cities Birmingham, Alabama • Los Angeles, California • San Francisco, California + 14 more
Conditions STEMI - ST Elevation Myocardial Infarction, AMI
Interventions KCCQ, Eq5D, cMRI (Subset of patients) Other
Lead sponsor TherOx Industry
Eligibility 18 Years to 80 Years
Enrollment 1,000 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2024 – 2029
U.S. locations 25
States / cities Fountain Valley, California • La Jolla, California • Laguna Hills, California + 21 more
Conditions Systemic Lupus Erythematosus
Interventions Hydroxychloroquine, Placebo Drug
Lead sponsor NYU Langone Health Other
Eligibility 55 Years and older
Enrollment 330 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2024 – 2029
U.S. locations 12
States / cities Los Angeles, California • San Diego, California • Atlanta, Georgia + 5 more
Conditions Erythroleukoplakia, Leukoplakia, Verrucous Oral Leukoplakia
Interventions Pembrolizumab Biological
Lead sponsor Jonsson Comprehensive Cancer Center Other
Eligibility 18 Years and older
Enrollment 26 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2019 – 2028
U.S. locations 3
States / cities La Jolla, California • Los Angeles, California
Conditions Colorectal Adenocarcinoma
Interventions Fluoxetine Drug
Lead sponsor Jonsson Comprehensive Cancer Center Other
Eligibility 18 Years and older
Enrollment 10 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2028
U.S. locations 1
States / cities Los Angeles, California About this UCLA Health institution page
What this page lists ClinicalTrials.gov records that list UCLA Health in Los Angeles, CA as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.
Related: all institution pages , browse by condition , or browse by U.S. city .